about
Bisphosphonate-anchored PEGylation and radiolabeling of superparamagnetic iron oxide: long-circulating nanoparticles for in vivo multimodal (T1 MRI-SPECT) imaging.Skeletal effects of zoledronic acid in an animal model of chronic kidney diseaseChronic kidney disease and osteoporosis: evaluation and management.Reduced fracture risk with early corticosteroid withdrawal after kidney transplant.Challenges in implementing and maintaining osteoporosis therapy.Denosumab for treatment of immobilization-related hypercalcaemia in a patient with advanced renal failureExtraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medicationsChronic kidney disease and the skeleton.Objective tumor response to denosumab in patients with giant cell tumor of bone: a multicenter phase II trial.Near IR fluorescent conjugated poly(ethylene glycol)bisphosphonate nanoparticles for in vivo bone targeting in a young mouse model.Bisphosphonates for Osteoporosis in Patients with Renal Insufficiency: Pharmacists' Practices and Beliefs.Clinical experience with intravenous zoledronic acid in the treatment of male osteoporosis: evidence and opinionsBisphosphonate-induced Severe Hypocalcemia - A Case Report -.Relationship between disease stage and renal function in bisphosphonate-related osteonecrosis of the jawOsteoporosis treatment: why ibandronic acid?Renal safety in patients treated with bisphosphonates for osteoporosis: a review.Management of osteoporosis in patients with chronic kidney disease.The use of bisphosphonates in women: when to use and when to stop.What Animal Models Have Taught Us About the Safety and Efficacy of Bisphosphonates in Chronic Kidney Disease.Clinically applicable antianginal agents suppress osteoblastic transformation of myogenic cells and heterotopic ossifications in mice.Renal impairment among postmenopausal women with osteoporosis from a large health plan in Israel.A phosphate-centric paradigm for pathophysiology and therapy of chronic kidney diseaseFactors associated with atypical femoral fracture.Changes of bone mineral density and serum pentosidine during a 27-month follow-up of monthly minodronate in osteoporotic patients.Minodronate for the treatment of osteoporosis.Engineering of a New Bisphosphonate Monomer and Nanoparticles of Narrow Size Distribution for Antibacterial ApplicationsImmunohistochemical expression of caspase-3, caspase-5, caspase-7 and apoptotic protease-activating factor-1 (APAF-1) in the liver and kidney of rats exposed to zoledronic acid (ZOL) and basic fibroblast growth factor (bFGF)Fragility Fractures in Chronic Kidney Disease: Assessment and Pharmacologic Management
P2860
Q30578977-5A8507B8-3D98-4576-BBAC-5C41A27CCB7AQ33779709-F1BF1233-7CAB-4845-82A5-8881A3D40DFCQ33833414-8AA8D0C8-07A8-449D-83B5-F6FD4AEE7318Q34069674-2741458A-1691-4A92-92E1-08A7BB036CF5Q34073740-61301B45-7BF1-41A6-88DE-34EDB85653E6Q35452966-6A681512-54F9-4D4D-BD26-142000335EB4Q35740351-547151ED-BB55-40DD-8702-98D377AC2416Q35755179-573C8172-DAA4-4098-8144-D8D9B124DC22Q36078358-EFDDA77F-78D3-4F3E-8B12-74E428159D6EQ36294187-CC44735E-65AB-419E-818C-1F1AC52C9BD4Q36649495-A3870C5C-A31B-4713-9ACE-6F9B4C41C914Q37058784-55521D4F-B861-41A0-9C90-401573229B63Q37192055-EF555B39-1599-4363-8044-EB692EB107F3Q37689304-BFD7BA5F-2A65-43EE-A629-B89C2BC98FEBQ38104738-5F6AABFE-208A-4749-BFCF-0DAC837289DFQ38125952-90C45BA2-2BC7-41E9-934C-DFE1D9D2ED88Q38187520-4F83BDB5-2ED2-442A-91E6-20C7651244D1Q38584336-43DADAEF-D3E4-4169-82A2-F79A24A06670Q38825566-E9B43403-4CBD-408E-ADD1-6F0075739E40Q39271486-3F91A155-9DB8-44BD-B925-E98EEC58C20EQ41262634-DB62E74F-6F7D-4767-AED4-5615C1A0A45BQ42727584-163CD7B0-12A3-43C9-8A96-A442C981A88BQ50534083-EECA1D4C-DCC7-4175-A09D-6B949AAB2FD3Q50789280-CA0487E4-0258-4159-99E8-DC592FF107B8Q55077666-1826D7DE-FF6B-4C75-ACCA-A97B3086DA5CQ56805984-F8F5CD04-2306-4B9E-B17A-DE40929EFA75Q57154970-AB3E31D2-ECB2-4C4E-B646-50B162553FA0Q59051207-0EC57DDE-EE86-440E-BED1-E141D6CCE343
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The kidney and bisphosphonates.
@en
The kidney and bisphosphonates.
@nl
type
label
The kidney and bisphosphonates.
@en
The kidney and bisphosphonates.
@nl
prefLabel
The kidney and bisphosphonates.
@en
The kidney and bisphosphonates.
@nl
P1433
P1476
The kidney and bisphosphonates.
@en
P2093
Paul D Miller
P356
10.1016/J.BONE.2010.12.024
P577
2011-01-11T00:00:00Z